Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health (INTEGRATE-CHW)

30 de octubre de 2026 actualizado por: Dr. Janet Diaz Martinez, Florida International University

Integrating Tailored Medical Nutrition Therapy and Community Health Worker Support to Advance Cardio-Kidney-Metabolic Health

This study tests whether adding CHW support to usual nutrition care helps adults with type 2 diabetes, hypertension, or chronic kidney disease manage their diet and health. At Caridad Center, a free clinic in Palm Beach County, Florida, usual care includes medical nutrition therapy from a registered dietitian and medically tailored groceries. Many patients find it hard to keep up dietary changes because of limited nutrition knowledge, cooking skills, food costs, and cultural fit.

Two hundred adults will be randomly assigned to usual care or usual care plus INTEGRATE-CHW, a 12-week program of six sessions with a trained CHW. In each session the participant selects one or two goals from the dietitian's plan and builds an action plan with the CHW. The dietitian remains responsible for the nutrition plan. The study will compare nutrition self-efficacy, nutrition literacy, diet quality, food security, and clinical measures between groups at baseline and Week 12. It will also evaluate how well the program fits into routine clinic care.

Descripción general del estudio

Descripción detallada

Dietitian-led MNT and medically tailored food programs improve diet quality and food security during active participation, but these gains often diminish once food delivery or counseling ends. Sustaining improvement requires ongoing behavioral reinforcement and self-management support that help patients adapt nutrition guidance to their cultural and household routines. This trial tests whether CHWs embedded in the dietitian's workflow can provide that reinforcement within routine care at a safety-net clinic.

The intervention is guided by Social Cognitive Theory, the Corbin and Strauss self-management framework, and Lorig and Holman's self-management skills. Self-efficacy serves as the central behavioral mechanism of change, operationalized through confidence-based goal setting, problem solving, and action planning. Enhanced self-efficacy is expected to improve adherence to dietary goals and, in turn, clinical cardio-kidney-metabolic indicators.

Aim 1 will determine the effect of INTEGRATE-CHW on behavioral outcomes. Aim 2 will examine preliminary effects on clinical outcomes. Aim 3 will evaluate implementation using mixed methods guided by RE-AIM and Proctor's framework, including semi-structured interviews with approximately 15 intervention participants and 5 staff (CHWs, registered dietitians, and clinic leads) exploring satisfaction, perceived burden, and workflow fit.

Analyses follow the intent-to-treat principle with two-sided tests (α = 0.05) and Benjamini-Hochberg false-discovery control. Between-group differences at Week 12 are estimated with analysis of covariance adjusting for baseline values. Behavioral models adjust for age, sex, language, baseline food insecurity, and CKD status. Clinical models adjust for age, sex, CKM profile, and medication classes (SGLT2 inhibitor, GLP-1 receptor agonist, ACE inhibitor/ARB, and statin use). Linear mixed-effects models are used for sensitivity analyses. Exploratory analyses test effect modification by baseline food insecurity, nutrition literacy level, and dominant CKM condition, and test whether changes in self-efficacy, literacy, or diet quality mediate changes in clinical indicators. A total of 200 participants (100 per arm) provides at least 80% power (α = 0.05) to detect a small-to-moderate effect (Cohen's d ≈ 0.35).

Tipo de estudio

Intervencionista

Inscripción (Estimado)

200

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Jordan Program coordinator
  • Número de teléfono: 305-348-4720
  • Correo electrónico: joquinta@fiu.edu

Ubicaciones de estudio

    • Florida
      • Boynton Beach, Florida, Estados Unidos, 33472
        • Caridad Center, Inc.

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Adults aged 18 years or older receiving care at Caridad Center
  • Documented diagnosis of type 2 diabetes (HbA1c ≥ 6.5%), hypertension (systolic blood pressure ≥ 130 mmHg), or chronic kidney disease Stages 1-4 (eGFR 15-59 mL/min/1.73 m² regardless of albuminuria, or eGFR ≥ 15 mL/min/1.73 m² with albuminuria ≥ 30 mg/g)
  • Eligible for medical nutrition therapy and medically tailored groceries through -Caridad Center
  • Able to provide informed consent in English or Spanish

Exclusion Criteria:

  • Dialysis or advanced kidney failure (CKD Stage 5; eGFR < 15 mL/min/1.73 m²)
  • Pregnancy
  • Cognitive impairment precluding participation
  • Plans to relocate during the 12-week intervention

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Investigación de servicios de salud
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: INTEGRATE-CHW

Usual care plus a 12-week CHW-delivered, nutrition-focused self-management support program: six sessions of approximately 60 minutes at Weeks 1, 3, 5, 7, 9, and 11, delivered in person or virtually by participant preference, and a Week 12 wrap-up aligned with the routine dietitian visit and laboratory review.

Trained CHWs deliver culturally tailored sessions using FlipChart visuals, pictorial goal cards, and recipe swaps. The curriculum covers diet and CKM links and home blood pressure and glucose monitoring (Session 1), diabetes (Session 2), hypertension (Session 3), CKD (Session 4), cardiometabolic integration (Session 5), and maintenance (Session 6). Participants select one to two goals from their dietitian's plan and build confidence-rated action plans. CHWs reinforce, but do not modify, dietitian guidance. Between sessions, CHWs provide reminder and follow-up contact by telephone or text message. Participants enter home blood pressure and glucose readings and goals into REDCap directly or with CHW assistance.

Comparador activo: Usual Care

Caridad Center standard care: individualized medical nutrition therapy from a registered dietitian approximately every three months and medically tailored groceries or meal boxes biweekly for 12 weeks.

Individualized medical nutrition therapy from a registered dietitian following the Academy of Nutrition and Dietetics' Nutrition Care Process, plus biweekly medically tailored groceries or meal boxes for 12 weeks.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change From Baseline in Nutrition Self-Efficacy Scale Score at Week 12
Periodo de tiempo: Baseline and Week 12

5-item Nutrition Self-Efficacy Scale, which measures confidence in maintaining healthy eating behaviors despite common barriers. Interviewer-administered in English or Spanish.

Baseline and Week 12
Change From Baseline in Short Food Literacy Questionnaire (SFLQ) Score at Week 12
Periodo de tiempo: Baseline and Week 12

12-item Short Food Literacy Questionnaire (SFLQ), which evaluates the ability to interpret nutrition information, read labels, and make balanced food choices. Interviewer-administered in English or Spanish.

Baseline and Week 12
Change From Baseline in Healthy Eating Index-2020 (HEI-2020) Total Score at Week 12
Periodo de tiempo: Baseline and Week 12

Healthy Eating Index-2020 (HEI-2020) total score, derived from two 24-hour dietary recalls.

Baseline and Week 12

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change From Baseline in USDA Six-Item Food Security Module Score at Week 12
Periodo de tiempo: Baseline and Week 12

USDA six-item food security module.

Baseline and Week 12
Change From Baseline in HbA1c (%) at Week 12
Periodo de tiempo: Baseline and Week 12

Glycated hemoglobin (%), extracted from the electronic medical record.

Baseline and Week 12
Change From Baseline in Systolic Blood Pressure (mmHg) at Week 12
Periodo de tiempo: Baseline and Week 12

Systolic blood pressure (mmHg), extracted from the electronic medical record.

Baseline and Week 12
Change From Baseline in Diastolic Blood Pressure (mmHg) at Week 12
Periodo de tiempo: Baseline and Week 12

Diastolic blood pressure (mmHg), extracted from the electronic medical record.

Baseline and Week 12
Change From Baseline in Body Mass Index (kg/m²) at Week 12
Periodo de tiempo: Baseline and Week 12

Body mass index (kg/m²), extracted from the electronic medical record.

Baseline and Week 12
Change From Baseline in Lipid Profile at Week 12
Periodo de tiempo: Baseline and Week 12

Lipid profile, extracted from the electronic medical record.

Baseline and Week 12
Change From Baseline in eGFR (mL/min/1.73 m²) at Week 12
Periodo de tiempo: Baseline and Week 12

eGFR (mL/min/1.73 m²), extracted from the electronic medical record.

Baseline and Week 12
Change From Baseline in Urinary Albumin-to-Creatinine Ratio (mg/g) at Week 12
Periodo de tiempo: Baseline and Week 12

uACR (mg/g), extracted from the electronic medical record; log-transformed and reported as ratios of geometric means.

Baseline and Week 12

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Feasibility: Proportion of Eligible Patients Who Enroll and Complete Follow-up
Periodo de tiempo: Enrollment through Week 12 follow-up

Proportion of eligible patients who enroll and complete follow-up.

Enrollment through Week 12 follow-up
Reach: Demographic Comparability of Enrolled Participants With the Clinic's CKM Population
Periodo de tiempo: Enrollment period

Demographic comparability between enrolled participants and the clinic's CKM population.

Enrollment period
Fidelity: Percentage of CHW Sessions Meeting All Required Elements
Periodo de tiempo: Weeks 1-12

Percentage of CHW sessions meeting all required elements, assessed through CHW session checklists, direct observation, and periodic audio review.

Weeks 1-12
Acceptability: Theoretical Framework of Acceptability (TFA) Survey Score
Periodo de tiempo: Week 12

Theoretical Framework of Acceptability (TFA) survey completed by intervention participants.

Week 12
Adoption: Proportion of RDs, CHWs, and Food Partners Delivering the Program as Intended
Periodo de tiempo: Up to 21 months (intervention delivery period)

Proportion of participating registered dietitians, CHWs, and food partners delivering the program as intended.

Up to 21 months (intervention delivery period)
Incremental Cost per Participant (US Dollars)
Periodo de tiempo: 12 weeks

Estimated from staff time, session duration, and supply costs, with cost per unit outcome.

12 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Janet Diaz Martinez, Florida International University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

15 de julio de 2027

Finalización primaria (Estimado)

30 de abril de 2029

Finalización del estudio (Estimado)

14 de enero de 2030

Fechas de registro del estudio

Enviado por primera vez

26 de octubre de 2026

Primero enviado que cumplió con los criterios de control de calidad

30 de octubre de 2026

Publicado por primera vez (Actual)

5 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

5 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

30 de octubre de 2026

Última verificación

1 de octubre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

Following publication of primary findings, de-identified datasets, data dictionaries, and codebooks will be made available through FIU's secure repository. Shared files will exclude personally identifiable information and contain only derived variables.

Marco de tiempo para compartir IPD

Following publication of primary findings; data will remain available for at least five years after project completion or publication of final results, whichever occurs later.

Criterios de acceso compartido de IPD

De-identified datasets, data dictionaries, codebooks, and analytic code will be available to researchers through FIU's institutional repository and, where applicable, the USDA Ag Data Commons, under FIU's Open Data Policy for research and educational re-use with attribution. Shared files will exclude personally identifiable information and contain only derived variables. Requests for restricted materials, such as qualitative transcripts, will require a data-use agreement and ethics approval.

Tipo de información de apoyo para compartir IPD

  • CÓDIGO_ANALÍTICO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir